Cargando…
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942476/ https://www.ncbi.nlm.nih.gov/pubmed/35338839 http://dx.doi.org/10.1016/S2213-2600(22)00123-0 |
| _version_ | 1784673314229190656 |
|---|---|
| author | Rangaka, Molebogeng X Hamada, Yohhei Abubakar, Ibrahim |
| author_facet | Rangaka, Molebogeng X Hamada, Yohhei Abubakar, Ibrahim |
| author_sort | Rangaka, Molebogeng X |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8942476 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89424762022-03-24 Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? Rangaka, Molebogeng X Hamada, Yohhei Abubakar, Ibrahim Lancet Respir Med Comment Elsevier Ltd. 2022-06 2022-03-23 /pmc/articles/PMC8942476/ /pubmed/35338839 http://dx.doi.org/10.1016/S2213-2600(22)00123-0 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Rangaka, Molebogeng X Hamada, Yohhei Abubakar, Ibrahim Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? |
| title | Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? |
| title_full | Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? |
| title_fullStr | Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? |
| title_full_unstemmed | Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? |
| title_short | Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? |
| title_sort | ending the tuberculosis syndemic: is covid-19 the (in)convenient scapegoat for poor progress? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942476/ https://www.ncbi.nlm.nih.gov/pubmed/35338839 http://dx.doi.org/10.1016/S2213-2600(22)00123-0 |
| work_keys_str_mv | AT rangakamolebogengx endingthetuberculosissyndemiciscovid19theinconvenientscapegoatforpoorprogress AT hamadayohhei endingthetuberculosissyndemiciscovid19theinconvenientscapegoatforpoorprogress AT abubakaribrahim endingthetuberculosissyndemiciscovid19theinconvenientscapegoatforpoorprogress |